---
input_text: 'Derivation of Huntington Disease affected Genea017 human embryonic stem
  cell line. The Genea017 human embryonic stem cell line was derived from a donated,
  fully commercially consented ART blastocyst, carrying Htt gene CAG expansion of
  40 repeats, indicative of Huntington Disease. Following ICM outgrowth on inactivated
  human feeders, genetic analysis confirmed a 46, XY karyotype and male allele pattern
  through CGH and STR analysis. The hESC line had pluripotent cell morphology, 87%
  of cells expressed Nanog, 95% Oct4, 88% Tra1-60 and 99% SSEA4, gave a PluriTest
  pluripotency score of 34.74, novelty of 1.27, demonstrated alkaline phosphatase
  activity and tri-lineage teratoma formation. The cell line was negative for Mycoplasma
  and visible contamination. '
raw_completion_output: |-
  primary_disease: Huntington Disease
  medical_actions: Derivation of Huntington Disease affected Genea017 human embryonic stem cell line; Genetic analysis; Alkaline phosphatase activity test; Tri-lineage teratoma formation test
  symptoms: 
  chemicals: 
  action_annotation_relationships: Derivation of Huntington Disease affected Genea017 human embryonic stem cell line PREVENTS symptoms IN Huntington Disease; Genetic analysis PREVENTS symptoms IN Huntington Disease; Alkaline phosphatase activity test PREVENTS symptoms IN Huntington Disease; Tri-lineage teratoma formation test PREVENTS symptoms IN Huntington Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Tri-lineage teratoma formation test PREVENTS symptoms IN Huntington Disease

  ===

extracted_object:
  primary_disease: MONDO:0007739
  medical_actions:
    - Derivation of Huntington Disease affected Genea017 human embryonic stem cell
      line
    - MAXO:0000127
    - Alkaline phosphatase activity test
    - Tri-lineage teratoma formation test
  action_annotation_relationships:
    - subject: <Derivation of Huntington Disease affected Genea017 human embryonic
        stem cell line>
      predicate: <PREVENTS>
      object: <symptoms>
      qualifier: <Huntington Disease>
      subject_extension: <Genea017 human embryonic stem cell line>
    - subject: MAXO:0000127
      predicate: PREVENTS
      object: symptoms
      qualifier: MONDO:0007739
    - subject: <Alkaline phosphatase activity test>
      predicate: <PREVENTS>
      object: <symptoms>
      qualifier: <Huntington Disease>
      subject_extension: <Alkaline phosphatase>
    - subject: <Tri-lineage teratoma formation test>
      predicate: <PREVENTS>
      object: <symptoms>
      qualifier: <Huntington Disease>
      subject_extension: <Tri-lineage teratoma>
named_entities:
  - id: MONDO:0005559
    label: Neurodegeneration
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0000708
    label: Behavioral changes
  - id: CHEBI:64645
    label: Beta-amyloid
  - id: CHEBI:36355
    label: Tau
  - id: MONDO:0002602
    label: Central Nervous System Diseases
  - id: HP:0000618
    label: Blindness
  - id: HP:0001658
    label: Myocardial infarction
  - id: MONDO:0007739
    label: Huntington disease
  - id: MAXO:0009017
    label: cognitive tests
  - id: HP:0001268
    label: cognitive decline
  - id: MONDO:0020074
    label: Progressive Myoclonic Epilepsy (PME)
  - id: MAXO:0000932
    label: Electroencephalography (EEG) studies
  - id: HP:0025464
    label: oxidative stress
  - id: CHEBI:16610
    label: Spermidine
  - id: CHEBI:16348
    label: 3-nitropropionic acid (3-NP)
  - id: CHEBI:16856
    label: Glutathione (GSH)
  - id: CHEBI:16301
    label: Nitrite
  - id: CHEBI:63895
    label: Interleukin (IL)-6
  - id: CHEBI:16865
    label: Gamma-aminobutyric acid (GABA)
  - id: CHEBI:29987
    label: Glutamate
  - id: CHEBI:17256
    label: Dopamine (DA)
  - id: CHEBI:33310
    label: Norepinephrine (NE)
  - id: CHEBI:28790
    label: 5-HT
  - id: CHEBI:41941
    label: 3,4-dihydroxyphenylacetic acid (DOPAC)
  - id: CHEBI:545959
    label: Homovanillic acid (HVA)
  - id: CHEBI:27823
    label: 5-hydroxyindoleacetic acid (5-HIAA)
  - id: CHEBI:16335
    label: Adenosine
  - id: CHEBI:17596
    label: Inosine
  - id: CHEBI:17368
    label: Hypoxanthine
  - id: HP:0003202
    label: muscle wasting
  - id: MAXO:0000127
    label: Genetic testing
  - id: MAXO:0000137
    label: PET scan
  - id: MONDO:0019260
    label: Adult Neuronal Ceroid Lipofuscinosis (ANCL)
  - id: CHEBI:53018
    label: dinitrophenol (DNP)
  - id: CHEBI:25675
    label: oligomycin
  - id: HP:0004305
    label: Involuntary movements
  - id: HP:0002072
    label: chorea
  - id: HP:0001824
    label: weight loss
  - id: CHEBI:27314
    label: water-soluble vitamins
  - id: CHEBI:46662
    label: minerals
  - id: MAXO:0000610
    label: Enzyme-linked immunosorbent assay
